PERFORMANCE
summary for the year

Since listing on the Johannesburg Stock Exchange (JSE) in 2008, AfroCentric has pursued opportunities to make healthcare more accessible and affordable. Our transformed and integrated service offerings enable us to optimise the healthcare value chain. Our significant growth has enabled us to become a sustainable and leading player in the healthcare business.

	Enhance shareholder value Dividend increased by 28% to			Promote transformation
	32 cents per share for the year			Level 21 Broad-Based Black Economic Empowerment (B-BBEE) status for the sixth consecutive year
	7% decrease in share price			2018 BHF Titanium Awards for Service Excellence: Administration and Managed Care
	Maximise growth opportunities			Diversify revenue sources
	Total revenue increased by 11.3%			Acquired MMed Distribution, Scriptpharm Risk Management, Essential Group and Tendahealth
	Acquired 24 000 members through Hosmed
	5 500 lives migrated from Community Medical Scheme to Bonitas after the liquidation			Deliver exceptional client service
	Contract volumes increased by approximately 20% through the award of a new set of provinces in the Central Chronic Medicine Dispensing and Distribution (CCMDD) contract with the Department of Health			Voice of the Customer survey achieved a positive response of 82.33%
	Improve efficiencies through cost consciousness			Uplift our people
	10.5% increase in operating profit			5 274 employee complement
	R343 million fraud, waste and abuse cases detected and confirmed			7 million in training spend
				Introduction of the Blue Print training centre
	Reduce the cost of healthcare
	R408 million cost savings based on Insurance Fraud Manager (IFM) software
	Year-on-year inflation on clients' hospital claims contained to 1%